Jurjen F. Krommenhoek

YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer

Bram Akerboom, Emily S.L. Martens, Milou A.M. Stals, Rolf E. Brouwer et autres

Importance: Although the YEARS algorithm is a safe and efficient way to rule out acute pulmonary embolism (PE), robust evidence on its accuracy in patients with cancer is lacking, and current guidelines suggest proceeding directly to computed tomographic pulmonary angiography (CTPA). Objective: …

nl, us, it, fr, ch, es, be, de (code pays fourni par la source)

Reply to Letter: “Bridging in Left Ventricular Assist Device Patients”

Eleonora Camilleri, Robin P. W. Roovers, Eva Janssen, Jurjen F. Krommenhoek et autres

nl (code pays fourni par la source)

Corrigendum to ‘Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway’

Jurjen F. Krommenhoek, Eleonora Camilleri, Thijs E. van Mens, Menno V. Huisman et autres

[This corrects the article DOI: 10.1016/j.rpth.2025.103183.].

Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway

Jurjen F. Krommenhoek, Eleonora Camilleri, Thijs E. van Mens, Menno V. Huisman et autres

Oral anticoagulation, although effective for the treatment and prevention of thromboembolic events, increases the risk of major bleeding. The acute management phase of anticoagulant-related major bleeding requires rapid decision-making and often involves multiple medical specialties. Guidelines offer some guidance for the acute …

nl (code pays fourni par la source)

Bridging Therapy and Risk of Bleeding and Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients: A Quasi-Experimental Study

Eleonora Camilleri, Robin P. W. Roovers, Eva Janssen, Jurjen F. Krommenhoek et autres

Bridging with low-molecular-weight heparin (LMWH) is recommended in continuous-flow left ventricular assist device (CF-LVAD) patients during subtherapeutic international normalized ratios (INRs). We aimed to assess the risk of adverse events during bridging in patients implanted at Leiden University Medical Center between 2010 …

nl (code pays fourni par la source)